GSK PLC (GS71.DE) Stock Price, Forecast & Analysis
Europe - FRA:GS71 - GB00BN7SWP63 - Common Stock
GS71.DE Key Statistics, Chart & Performance
The current stock price of GS71.DE is 20.25 EUR. In the past month the price increased by 7.06%. In the past year, price increased by 19.96%.
GS71.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1SAN.MI | SANOFI | 11.48 | 212.63B | ||
| SAN.PA | SANOFI | 11.24 | 208.26B | ||
| SNW.DE | SANOFI | 11.25 | 208.42B | ||
| 1MRK.MI | MERCK KGAA | 13.35 | 49.41B | ||
| MRK.DE | MERCK KGAA | 12.81 | 47.41B | ||
| UCB.BR | UCB SA | 35.56 | 44.41B | ||
| BAYN.DE | BAYER AG-REG | 5.2 | 25.61B | ||
| 1BAYN.MI | BAYER AG-REG | 5.28 | 26.00B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 25.2 | 10.38B | ||
| IPN.PA | IPSEN | 11.99 | 10.32B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 98.8 | 9.15B | ||
| VIRP.PA | VIRBAC SA | 19.84 | 2.89B |
Related stock screener links
About GS71.DE
Company Profile
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. The company is headquartered in Brentford, Middlesex and currently employs 68,629 full-time employees. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Its specialty medicines prevent and treat diseases, from human immunodeficiency virus (HIV) to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines to protect people from a range of diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).
Company Info
GSK PLC
980 Great West Road
Brentford MIDDLESEX GB
Employees: 68629
Phone: 442080475000
GSK PLC / GS71.DE FAQ
Can you describe the business of GSK PLC?
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. The company is headquartered in Brentford, Middlesex and currently employs 68,629 full-time employees. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Its specialty medicines prevent and treat diseases, from human immunodeficiency virus (HIV) to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines to protect people from a range of diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).
Can you provide the latest stock price for GSK PLC?
The current stock price of GS71.DE is 20.25 EUR. The price decreased by -0.59% in the last trading session.
What is the dividend status of GSK PLC?
GSK PLC (GS71.DE) has a dividend yield of 3.59%. The yearly dividend amount is currently 0.68.
How is the ChartMill rating for GSK PLC?
GS71.DE has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What sector and industry does GSK PLC belong to?
GSK PLC (GS71.DE) operates in the Health Care sector and the Pharmaceuticals industry.
GS71.DE Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to GS71.DE. When comparing the yearly performance of all stocks, GS71.DE is one of the better performing stocks in the market, outperforming 87.45% of all stocks.
GS71.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to GS71.DE. GS71.DE has an excellent profitability rating, but there are concerns on its financial health.
GS71.DE Financial Highlights
Over the last trailing twelve months GS71.DE reported a non-GAAP Earnings per Share(EPS) of 2.57. The EPS increased by 37.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.08% | ||
| ROA | 8.96% | ||
| ROE | 34.02% | ||
| Debt/Equity | 0.92 |
GS71.DE Forecast & Estimates
31 analysts have analysed GS71.DE and the average price target is 19.33 EUR. This implies a price decrease of -4.54% is expected in the next year compared to the current price of 20.25.
For the next year, analysts expect an EPS growth of 4.82% and a revenue growth 3.11% for GS71.DE